| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Alexander Cumbo | President and CEO | 2026-02-18 | 16,644 | $5.82 | $96.92kSell |
| Jessie Hanrahan | Chief Regulatory Officer | 2026-02-18 | 4,134 | $5.82 | $24.07kSell |
| Ilan Ganot | Director | 2026-02-18 | 2,658 | $5.82 | $15.48kSell |
| David T. Howton | Chief Operating Officer | 2026-02-18 | 7,469 | $5.82 | $43.49kSell |
| Paul Herzich | Chief Technology Officer | 2026-02-18 | 3,616 | $5.82 | $21.06kSell |
| Kevin Tan | CFO Treasurer | 2026-02-18 | 5,404 | $5.82 | $31.47kSell |
| Jessie Hanrahan | Chief Regulatory Officer | 2026-02-04 | 12,348 | $6.44 | $79.55kSell |
| Gabriel Brooks | Chief Medical Officer | 2026-02-04 | 12,616 | $6.44 | $81.27kSell |
| Alexander Cumbo | President and CEO | 2026-02-04 | 48,913 | $6.44 | $315.10kSell |
| Ilan Ganot | Director | 2026-02-04 | 7,205 | $6.44 | $46.41kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Rajeev M. Shah | 13.50% | 13,281,046 | $94.69M | Insider |
| Perceptive Advisors LLC | 12.03% | 11,833,539 | $84.37M | Institution |
| Ra Capital Management LP | 11.88% | 11,689,948 | $83.35M | Insider |
| Bain Capital Life Sciences Investors LLC | 8.04% | 7,911,669 | $56.41M | Institution |
| Ultragenyx Pharmaceutical Inc | 7.95% | 7,825,797 | $55.80M | Insider |
| Siren LLC | 7.82% | 7,690,405 | $54.83M | Institution |
| Vestal Point Capital LP | 5.91% | 5,815,000 | $41.46M | Institution |
| Ra Capital Management LP | 5.91% | 5,811,423 | $41.44M | Institution |
| Gilad David Hayeem | 5.22% | 5,136,501 | $36.62M | Insider |
| Bain Capital Life Sciences Investors LLC | 5.12% | 5,034,582 | $35.90M | Insider |